Against this background, we set out to attach ANP to HA‐GNPs in order to create a nanocarrier combining two properties: a high ocular delivery rate due to a HA coat and antitumorigenic qualities due to attached ANP to effectively reduce RB tumor growth. This evidence concerns the gene NPPA and retinoblastoma.